Article

The Target Atlas for Antibody-Drug Conjugates across Solid Cancers

2023-05-10

Abstract excerpt

Antibody-Drug Conjugates (ADCs) is a rapidly developing type of oncology therapeutic, spanning the targeted therapy for hematologic malignancies and solid cancers. A major requirement in ADC research is the identification of ideal surface antigens that can distinguish target cells from most mammalian cell types. Herein, we develop an algorithm and comply a comprehensive cell membrane protein annotation dataset int...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e5660d7d-96f9-56af-8b2c-f2df5c9e5d41
DOI: 10.21203/rs.3.rs-2884661/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The Target Atlas for Antibody-Drug Conjugates across Solid CancersDOI 10.21203/rs.3.rs-2884661/v1Read

Expanding the repertoire of Antibody Drug Conjugate (ADC) targets with improved tumor selectivity and range of potent payloads through in-silico analysis.Semantic proximity Read

Identification of cell surface targets for CAR-T cell therapies and antibody–drug conjugates in breast cancerSemantic proximity Read

Current transcriptome database and biomarker discovery for immunotherapy by immune checkpoint blockadeSemantic proximity Read

Interconnecting ADC Structure with Tumor Cell Biology with Multimodal LearningSemantic proximity Read

Pan-cancer proteogenomics expands the landscape of therapeutic targetsSemantic proximity Read

Clinical Potential of Antibody–Drug Conjugates in Early-Phase Clinical Trials for Late-Line Treatment of Advanced Solid TumorsSemantic proximity Read

A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastomaSemantic proximity Read

An Array of 60,000 Antibodies for Proteome-Scale Antibody Generation and Target DiscoverySemantic proximity Read

AI supported in silico screening of chimeric antigen receptor therapy targetsSemantic proximity Read

Pan-Cancer Proteomics Analysis to Identify Tumor-Enriched and Highly Expressed Cell Surface Antigens as Potential Targets for Cancer TherapeuticsSemantic proximity Read

A TCR mimic CAR T cell specific for NDC80 is broadly reactive with solid tumors and hematologic malignanciesSemantic proximity Read

Pan-cancer Proteomics Analysis to Identify Tumor-Enriched and Highly Expressed Cell Surface Antigens as Potential Targets for Cancer TherapeuticsSemantic proximity Read